Welcome to our dedicated page for Zurn Elkay Water Solutions SEC filings (Ticker: ZWS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Zurn Elkay Water Solutions Corporation (NYSE: ZWS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Zurn Elkay’s common stock is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades on the New York Stock Exchange under the symbol ZWS, so its filings offer detailed insight into its water management business.
Investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q to understand Zurn Elkay’s financial condition, risk factors and discussion of operations. These core filings complement the company’s description as a growth-oriented, pure-play water management business with a specification-driven portfolio of water safety and control products, flow systems products, hygienic and environmental products and filtered drinking water products.
The company also files current reports on Form 8-K to furnish earnings releases and other material events. Recent 8-K filings have been used to provide quarterly financial results for specific periods, including net sales, income from operations and adjusted EBITDA, along with management commentary. These filings help investors track short-term performance and any significant developments that Zurn Elkay chooses to disclose between periodic reports.
On this page, Stock Titan surfaces Zurn Elkay’s SEC filings in real time as they appear on EDGAR and enhances them with AI-powered summaries. These summaries are intended to highlight key points in lengthy documents, such as major changes in financial metrics, updates on the company’s water management portfolio, or notable risk disclosures, without replacing the full text of the filings.
Users can also access insider transaction reports on Form 4, proxy statements on Schedule 14A and other relevant forms as they become available. Together, these filings provide a structured view of Zurn Elkay Water Solutions’ regulatory reporting, supporting deeper analysis of the company’s governance, compensation disclosures and capital markets activity.
Zurn Elkay Water Solutions Corporation delivered solid growth in the quarter ended March 31, 2026. Net sales rose to $433.0 million from $388.8 million, an 11% increase driven by higher core sales across nearly all product categories.
Income from operations increased to $82.1 million from $63.4 million, lifting operating margin to 19.0% from 16.3%. Net income grew to $58.9 million, with diluted EPS up to $0.35 from $0.26, while restructuring charges declined.
The company generated $46.1 million in operating cash flow and ended the quarter with $273.5 million in cash and $499.0 million of total debt. It enlarged its revolving credit facility to $550.0 million and repurchased 1,047,291 shares for $50.0 million while paying $18.4 million in dividends.
Zurn Elkay Water Solutions reported solid first quarter 2026 results, with net sales rising to $433.0 million from $388.8 million, an 11% increase driven by broad-based core sales growth. Net income from continuing operations grew to $58.9 million, with diluted EPS from continuing operations of $0.35 versus $0.24 a year earlier.
Adjusted EPS was $0.41, up from $0.31, and adjusted EBITDA increased to $116.0 million from $98.0 million, expanding margins to 26.8% of net sales. The company reported net debt leverage of 0.5x, increased revolver capacity to $550 million, and repurchased $50 million (1.0 million shares) of common stock in the quarter. For the second quarter 2026, management expects core sales to grow 8–9% year over year and adjusted EBITDA margins between 27.0% and 27.5%, noting potential upside to its full-year 2026 outlook.
Zurn Elkay Water Solutions Corp director George C. Moore reported receiving an equity grant tied to his board compensation. On this Form 4, he acquired 660 shares of Common Stock at $47.39 per share as a grant/award, not an open-market purchase.
After this award, Moore directly holds 120,292 shares of Zurn Elkay common stock. According to the footnote, the grant represents payment of director fees in restricted stock units, which vested immediately but will not be paid out until six months after he stops serving as a director.
Zurn Elkay Water Solutions Corp director Peggy Troy received an equity-based fee on April 15, 2026. She acquired 607 shares of Common Stock at $47.39 per share as a grant or award, bringing her direct holdings to 65,124 shares after the transaction.
The award represents payment of director fees in the form of restricted stock units. These units vested immediately, but will not be paid out in shares until six months after her service as a director ends.
CHRISTOPOUL THOMAS reported acquisition or exercise transactions in this Form 4 filing.
Zurn Elkay Water Solutions director Thomas Christopoul received an award of 634 shares of Common Stock on April 15, 2026, valued at $47.39 per share, as payment of director fees in the form of restricted stock units. These units vested immediately but will not be paid out until six months after he stops serving as a director. Following this compensation-related grant, he holds 117,805 shares directly.
Longren David C. reported acquisition or exercise transactions in this Form 4 filing.
Zurn Elkay Water Solutions director David C. Longren received 607 shares of Common Stock as a grant on April 15, 2026, at $47.39 per share. The shares represent payment of director fees in restricted stock units that vested immediately, with payout deferred until six months after his service as a director ends. Following this grant, he holds 98,217 shares directly.
Schooler Rosemary reported acquisition or exercise transactions in this Form 4 filing.
Zurn Elkay Water Solutions director Rosemary Schooler reported receiving 528 shares of common stock as a grant tied to director fees. The award is structured as restricted stock units that vested immediately at a reference price of $47.39 per share and increases her direct holdings to 61,772 shares. Although vested, the units are not paid out until six months after she ceases serving as a director, highlighting that this is compensation-related rather than an open-market purchase.
Zurn Elkay Water Solutions Corp ownership filing shows The Vanguard Group reports 0 shares beneficially owned after an internal realignment. The amendment states certain Vanguard subsidiaries will report holdings separately in reliance on SEC Release No. 34-39538, and Vanguard no longer is deemed to beneficially own those subsidiary positions.
The filing is signed by Ashley Grim as Head of Global Fund Administration on 03/27/2026, and states the registrant's principal office at 100 Vanguard Blvd., Malvern, PA.
Zurn Elkay Water Solutions is asking stockholders to vote on three items at its April 30, 2026 annual meeting in Milwaukee. Proposal 1 elects three directors—Thomas D. Christopoul, Emma M. McTague and Peggy N. Troy—for terms ending in 2029. Proposal 2 is an advisory vote on executive pay, which is heavily performance-based and reviewed with input from stockholders and an independent compensation consultant. Proposal 3 seeks ratification of Ernst & Young LLP as independent auditor for 2026; EY has served the company or its predecessors since 2002, with 2025 audit fees of $1,501,458 and tax fees of $169,539. Stockholders of record on March 3, 2026, when 167,542,304 common shares were outstanding, may vote by internet, phone, mail, or in person. The proxy also details board independence, committee structure, robust sustainability and cybersecurity oversight, and director compensation combining cash retainers and stock-based awards.